Notify me when Sofinnova Investments, Inc. files a new 13F portfolio report.
⭐ Subscribe ⭐| Quarter | Holdings | Value $ | Bought | Sold | Net | Top Holdings | Form Type | Filing Time |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | 60 | $2,319,284,145 | +$621,601,233 | -$507,160,002 | +$114,441,231 | NTRA, JAZZ, AZN, VERA, BMY | 13F-HR | 13 Feb 2026, 15:26 |
| Q3 2025 | 55 | $1,630,150,121 | +$349,554,735 | -$505,935,689 | -$156,380,954 | NTRA, GILD, VERA, UTHR, JAZZ | 13F-HR | 13 Nov 2025, 18:40 |
| Q2 2025 | 55 | $1,469,701,421 | +$451,357,506 | -$408,331,970 | +$43,025,536 | NTRA, GILD, LLY, JAZZ, VERA | 13F-HR | 14 Aug 2025, 15:09 |
| Q1 2025 | 59 | $1,326,074,961 | +$477,302,180 | -$366,151,000 | +$111,151,180 | NTRA, SYK, VERA, JAZZ, MDT | 13F-HR | 15 May 2025, 13:46 |
| Q4 2024 | 60 | $1,364,403,097 | +$504,102,907 | -$282,736,650 | +$221,366,257 | NTRA, VERA, GILD, ABBV, JAZZ | 13F-HR | 14 Feb 2025, 13:34 |
| Q3 2024 | 57 | $1,208,353,607 | +$221,127,797 | -$662,775,104 | -$441,647,307 | NTRA, VERA, NVO, AZN, IDYA | 13F-HR | 13 Nov 2024, 14:20 |
| Q2 2024 | 72 | $1,586,926,722 | +$459,944,263 | -$432,712,017 | +$27,232,246 | NTRA, VERA, ASND, NVO, EW | 13F-HR | 09 Aug 2024, 15:50 |
| Q1 2024 | 67 | $1,694,515,067 | +$650,660,901 | -$1,028,763,705 | -$378,102,804 | NTRA, VERA, ASND, AVTE, MRK | Restatement | 14 Aug 2024, 14:30 |
| Q4 2023 | 60 | $1,785,185,211 | +$275,011,596 | -$503,374,793 | -$228,363,197 | KRTX, RYZB, NTRA, ASND, MRK | Restatement | 15 Aug 2024, 13:59 |
| Q3 2023 | 52 | $1,439,213,323 | +$380,799,314 | -$265,343,944 | +$115,455,370 | KRTX, NTRA, AZN, MRK, ASND | 13F-HR | 14 Nov 2023, 16:11 |
| Q2 2023 | 48 | $1,514,807,979 | +$398,855,164 | -$506,758,635 | -$107,903,471 | KRTX, NTRA, AZN, ISRG, ASND | 13F-HR | 14 Aug 2023, 14:51 |
| Q1 2023 | 49 | $1,474,876,999 | +$332,546,412 | -$466,982,804 | -$134,436,392 | KRTX, NTRA, MRK, ASND, AVTE | 13F-HR | 11 May 2023, 13:06 |
| Q4 2022 | 46 | $1,645,620,641 | +$329,847,245 | -$164,653,481 | +$165,193,764 | KRTX, NTRA, AVTE, ASND, SNY | 13F-HR | 13 Feb 2023, 19:53 |
| Q3 2022 | 51 | $1,572,701,000 | +$246,740,396 | -$143,244,605 | +$103,495,791 | KRTX, CINC, NTRA, VERA, AVTE | 13F-HR | 08 Nov 2022, 13:37 |
| Q2 2022 | 53 | $1,124,066,000 | +$209,736,205 | -$179,352,403 | +$30,383,802 | KRTX, NTRA, CINC, AVTE, ASND | 13F-HR | 15 Aug 2022, 14:19 |
| Q1 2022 | 54 | $1,190,129,000 | +$277,260,721 | -$356,485,878 | -$79,225,157 | KRTX, NTRA, CINC, VERA, AVTE | 13F-HR | 13 May 2022, 18:45 |
| Q4 2021 | 61 | $1,560,318,000 | +$348,493,944 | -$218,286,636 | +$130,207,308 | NTRA, KRTX, VERA, RHHBY, ASND | 13F-HR | 14 Feb 2022, 11:23 |
| Q3 2021 | 61 | $1,559,794,000 | +$188,179,160 | -$258,460,010 | -$70,280,850 | NTRA, KRTX, ASND, AVTE, AZN | 13F-HR | 15 Nov 2021, 13:27 |
| Q2 2021 | 61 | $1,645,845,000 | +$322,317,446 | -$227,145,717 | +$95,171,729 | NTRA, KRTX, AVTE, YMAB, ASND | 13F-HR | 16 Aug 2021, 13:18 |
| Q1 2021 | 60 | $1,585,588,000 | +$371,884,068 | -$340,435,707 | +$31,448,361 | NTRA, KRTX, BOLT, ASND, YMAB | 13F-HR | 14 May 2021, 14:37 |
| Q4 2020 | 63 | $1,612,852,000 | +$251,121,403 | -$162,537,377 | +$88,584,026 | NTRA, KRTX, ASND, YMAB, UTHR | 13F-HR | 16 Feb 2021, 16:04 |
| Q3 2020 | 62 | $1,276,327,000 | +$235,759,256 | -$355,831,975 | -$120,072,719 | NTRA, ASND, KRTX, YMAB, INZY | 13F-HR | 12 Nov 2020, 19:44 |
| Q2 2020 | 66 | $1,457,655,000 | +$300,996,372 | -$174,425,127 | +$126,571,245 | KRTX, ASND, NTRA, YMAB, PRNB | 13F-HR | 13 Aug 2020, 17:12 |
| Q1 2020 | 58 | $1,054,283,000 | +$112,939,093 | -$180,364,638 | -$67,425,545 | KRTX, ASND, NXTC, NTRA, PRNB | 13F-HR | 12 May 2020, 21:15 |
| Q4 2019 | 56 | $1,358,396,000 | +$226,203,572 | -$278,980,909 | -$52,777,337 | ASND, NXTC, KRTX, AMRN, NTRA | 13F-HR | 13 Feb 2020, 20:49 |
| Q3 2019 | 65 | $1,055,403,000 | +$157,862,094 | -$85,066,916 | +$72,795,178 | ASND, NTRA, AMRN, NXTC, YMAB | 13F-HR | 14 Nov 2019, 15:42 |
| Q2 2019 | 62 | $1,055,355,000 | +$200,973,990 | -$92,048,738 | +$108,925,252 | ASND, AMRN, NTRA, PRNB, OBSVF | 13F-HR | 12 Aug 2019, 19:02 |
| Q1 2019 | 59 | $979,598,000 | +$82,845,751 | -$180,209,839 | -$97,364,088 | ASND, AMRN, PRNB, NTRA, OBSVF | 13F-HR | 15 May 2019, 15:00 |
| Q4 2018 | 59 | $802,715,000 | +$143,909,968 | -$187,801,298 | -$43,891,330 | ASND, AMRN, OBSVF, PRNB, NTRA | Restatement | 22 Feb 2019, 12:07 |
| Q3 2018 | 59 | $1,114,095,000 | +$256,384,424 | -$108,600,369 | +$147,784,055 | ASND, Nucana Biomed, OBSVF, AMRN, NTRA | 13F-HR | 14 Nov 2018, 17:40 |
| Q2 2018 | 57 | $870,777,000 | $0 | $0 | $0 | ASND, Nucana Biomed, OBSVF, NTRA, MRUS | New Holdings | 14 Nov 2018, 17:41 |
| Q2 2018 | 57 | $870,777,000 | +$319,684,622 | -$110,560,895 | +$209,123,727 | ASND, Nucana Biomed, OBSVF, NTRA, MRUS | 13F-HR | 14 Aug 2018, 10:27 |
| Q1 2018 | 51 | $581,135,000 | $0 | $0 | $0 | ASND, NCNA, OBSVF, BOLD, MRUS | 13F-HR | 15 May 2018, 12:37 |